Connect with us

Technologies

FDA, Pfizer delay authorization for COVID vaccine for kids under 5: What to know

The FDA will review data on all three doses of the vaccine for young kids, instead of starting with just two. The data should be available in early April.

For the most up-to-date news and information about the coronavirus pandemic, visit the WHO and CDC websites.

Parents of children under 5 will have to wait a little longer to get their kids vaccinated against COVID-19.

Pfizer and BioNTech announced Friday that the companies are extending their “rolling submission” process for the vaccine for kids 6 months through 4 years and are waiting for more data on all three doses before asking the US Food and Drug Administration to authorize the first two shots. Just two doses of the vaccine weren’t effective for the whole age group.

The FDA said on Friday that the agency is postponing its Feb. 15 committee meeting, which would’ve included a vote on whether to move forward with the first doses of the COVID-19 vaccine for young kids. The agency said that it will provide an updated time for a new meeting once the FDA receives additional data for the full vaccine.

“The extension allows the FDA time to receive updated data on the two- and three-dose regimen, conduct a thorough evaluation of it, and facilitate a robust, public discussion,” Pfizer and BioNTech said in the announcement. The companies expect to have three-dose protection data by early April, they said.

Last week, Pfizer and BioNTech submitted data to the FDA for authorization of their COVID-19 vaccine for children 6 months through 4 years old. While the vaccine for children under 5 is expected to be a three-dose vaccine series (it’s one-tenth the volume of Pfizer’s vaccine for people 12 and up), the FDA asked the companies to submit data on the first two doses as part of a “rolling submission” process.

In December, Pfizer announced that while two doses of the vaccine were effective in children ages 6 months to 2 years, two shots failed to promote a strong enough immune response in children ages 2 through 4 years. This prompted the company to start testing a three-dose version of the vaccine for children under 5.

Updated Sunday, the Centers for Disease Control and Prevention’s Pediatric COVID-19 Vaccination Operational Planning Guide indicates that the agency has 10 million vaccine doses ready for dispersal, and that state and local health officials could start receiving doses as early as Feb. 21. Without FDA authorization beforehand, this will be postponed.

Kids as young as 5 have been able to be vaccinated against COVID-19 since October 2021. The Kaiser Family Foundation reports that 28.1% of kids 5 to 11 have received at least one vaccine shot as of Jan. 18. Read on to learn everything you need to know about COVID-19 vaccines for kids under 5.

Also, learn about whether we’ll need a fourth booster shot, the latest on long COVID and the possibility of a vaccine that works against all COVID-19 variants.

Why did Pfizer and the FDA extend the authorization process?

At the FDA’s request, Pfizer and BioNTech started the submission process last week for authorization of the first two doses of the vaccine for kids 6 months through 4 years last week.

But in a statement Friday, the FDA said: “Based on the agency’s preliminary assessment, and to allow more time to evaluate additional data, we believe additional information regarding the ongoing evaluation of a third dose should be considered as part of our decision-making for potential authorization.”

The vaccine for children under 5 covers kids 6 months through 4 years. While two shots of the smaller-dose vaccine were effective in babies and toddlers 6 months to 2 years, receiving only two doses failed to promote a strong immune response in children 2 to 4 years. Studies on a third dose are ongoing, but expected to complete the series for kids under 5.

“Given that the study is advancing at a rapid pace, the companies will wait for the three-dose data as Pfizer and BioNTech continue to believe it may provide a higher level of protection in this age group,” the companies said Friday.

The extension of the rolling submission process for the vaccine for kids under 5 comes as a disappointment for many parents wanting to protect their younger children against COVID-19, but it’s more in line with earlier estimates from public health officials on when a COVID-19 vaccine might be available for the age group.

When can babies and children under 5 get the vaccine?

Once Pfizer and BioNTech submit additional information to the FDA, a committee of experts that gathers to discuss safety and effectiveness data and vote on whether or not the FDA should authorize a vaccine will meet. The agency will provide an update on timing for the meeting on the vaccine for kids under 5 once they receive more data, FDA Commissioner Dr. Janet Woodcock and Dr. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research said in a statement Friday.

“This will give the agency time to consider the additional data, allowing for a transparent public discussion as part of our usual scientific and regulatory processes for COVID-19 vaccines,” the doctors said.

The advisory committee’s meetings are open to the public.

If the FDA does authorize Pfizer’s vaccine for children as young as 6 months old, the CDC typically goes through the same process: An outside panel of health experts will discuss the benefits and risks of recommending the vaccine to children under 5 years old. If they vote to recommend Pfizer’s vaccine for the younger age group, the CDC’s director will likely accept the panel’s decision and the small doses of Pfizer’s COVID-19 vaccine for kids will become available in pediatricians’ offices or other clinics.

Pfizer and BioNTech’s COVID-19 vaccine is not the only one being studied in kids under 5, however. Moderna said in January that it expects to report vaccine data on children 2 to 5 years in March. In a few countries outside the US, including Canada, Moderna’s vaccine has received regulatory authorizations for adolescents 12 and up.

How is Pfizer’s child vaccine for young kids different?

Pfizer and BioNTech’s vaccine for children 6 months through 4 years comes in two doses that are one-tenth the volume of the vaccine for people age 12 and up. A third 3-microgram dose is being researched right now is expected to complete the series.

The vaccine for kids 5 to 11 is one-third the dose given to everyone 12 and up, and it’s delivered in two doses. Pfizer’s vaccine for kids can also be stored for up to 10 weeks in a fridge, making it easier to administer, and the cap on the vial is orange instead of purple and gray to avoid mix-ups.

And if it helps to put your kids at ease, the needle used to administer the child’s dose of vaccine is also smaller.

For more information about Pfizer’s vaccine for children ages 5 to 11, check out this fact sheet from the FDA.

Can my child get a COVID booster?

Children as young as 12 can now get a booster dose of Pfizer’s COVID-19 vaccine, given at least five months after their primary vaccination series.

Most kids younger than 12 can’t get a booster, although the CDC recommends a third dose of the Pfizer vaccine for children 5 and up who are immunocompromised. They’re eligible for a third shot 28 days after their second dose.

Where can my kid get a booster shot?

Since Pfizer’s COVID-19 vaccine is the lone vaccine approved for people under 18, it’s generally only available in doctor’s offices and public health clinics, not pharmacies and other mass vaccination sites.

Call your pediatrician or local health clinic for a recommendation on where to go. Parents may also text their ZIP code to 438829 or use this vaccine finder link to find a clinic near them that has the child vaccine available.

Do kids really need a COVID-19 vaccine?

According to a report from the American Academy of Pediatrics, children made up 25% of reported COVID-19 cases for the week ending Feb. 3. (The AAP says the definition of “child” varies by the states reporting.) While pediatric cases were lower than in January, child COVID-19 were “double the peak level of the delta surge in 2021,” the AAP reported.

While it’s true children are much less likely to get severely sick from the virus than adults, some children have died or been hospitalized with the virus. An infection, even a mild case, requires quarantining and potentially sending classmates out of the classroom and back to remote learning. And kids can experience dangerous complications from COVID-19, including long COVID and MIS-C.

There are also racial disparities in the severity of how sick children get from COVID-19: Kids ages 5 to 11 who are Black, Native American or Hispanic are three times more likely to be hospitalized with COVID-19 than white children, according to an FDA advisory panel presentation. Of that group, about 1 in 3 will require admission to an intensive care unit.

Are booster shots safe for children?

In a statement following its authorization of booster doses for kids 12 to 15, the FDA said it reviewed real-world data from more than 6,300 children in Israel, ages 12 to 15, who received a booster shot at least five months after their second dose of Pfizer.

No additional safety concerns were reported to date in those individuals, according to the FDA.

“These additional data enabled the FDA to reassess the benefits and risks of the use of a booster in the younger adolescent population in the setting of the current surge in COVID-19 cases,” the agency said. “The data shows there are no new safety concerns following a booster in this population.”

What are the side effects? Is the COVID vaccine safe for kids?

Vaccine side effects in kids ages 5 to 11 are mostly mild and similar to those adults may experience, according to the CDC, including soreness at the injection site, fever, muscle soreness, nausea and fatigue. In a Dec. 13 report from the agency, the CDC reviewed reports from safety monitoring systems on more than 8 million doses of Pfizer’s vaccine given to kids ages 5 to 11, confirming that children’s immune systems respond well to the vaccine with common mild side effects, and that serious adverse events are rarely reported.

Inflammation of the heart muscle, known as myocarditis, and of the muscle’s outer lining, called pericarditis, are rare and typically mild side effects linked to the Moderna and Pfizer vaccines, mostly in adolescent males and young men ages 12 to 29. (Myocarditis can also occur after infection with COVID-19.)

In one study, the CDC said that 54 recipients out of a million males ages 12 to 17 experienced myocarditis following the second dose of Pfizer-BioNTech’s Comirnaty vaccine. In contrast, kids ages 5 to 11 who catch COVID-19 have a higher risk of multisystem inflammatory syndrome, or MIS-C, a potentially serious complication involving inflammation of the heart, lungs, kidneys, brain, skin, eyes or other organs.

“The bottom line is that getting COVID is much riskier to the heart than anything in this vaccine, no matter what age or sex you are,” Dr. Matthew Oster, a pediatric cardiologist at Children’s Healthcare of Atlanta, told the CDC in November as reported by ABC News.

Do I need to give consent for my young child to get vaccinated?

Yes, parents generally need to consent to their children receiving medical care, including Pfizer’s COVID-19 vaccine. This is especially true for younger children.

However, depending on which state you live in, there may be a legal precedent for teens and other kids to request the vaccine without parental permission: Tennessee’s vaccine director, Michelle Fiscus, was fired in August allegedly in part for sending out a memo detailing Tennessee’s “mature minor doctrine,” which explains how minors may seek medical care without the consent of their parents.

If my child has a serious health condition, can they get a third shot?

The CDC recommended a third dose for children as young as 5 who are “moderately to severely” immunocompromised, 28 days after their second shot. This guidance for immunocompromised children (including kids who’ve had an organ transplant or are taking medications that suppress the immune system) is in line with guidance for adults whose bodies don’t mount a good immune response to the COVID-19 vaccines.

My child has allergies. Can they get the vaccine?

Yes, though you might be asked to stick around the waiting room so health care providers can monitor them for (extremely rare) allergic reactions that can occur after any vaccination.

“If the child has a history of anaphylaxis or other severe allergies, then the observation time after the injection may be 30 minutes instead of 15,” said Dr. Anne Liu, an infectious disease specialist with Stanford Hospital and Clinics and the Lucile Packard Children’s Hospital. Children who have been prescribed an EpiPen for any reason should bring it to their vaccine appointment, Liu added.

As with adults, children with an allergy to an ingredient in Pfizer’s COVID-19 shouldn’t take it. You can find a list of ingredients in Pfizer’s vaccine for kids ages 5 to 11 on the FDA’s fact sheet.

Can my child get the COVID-19 shot at the same time as other vaccines?

According to the CDC, your child may get other vaccines when they go in for their COVID shot without waiting 14 days between appointments. Flu shots can be given to children ages 6 months and older.

The information contained in this article is for educational and informational purposes only and is not intended as health or medical advice. Always consult a physician or other qualified health provider regarding any questions you may have about a medical condition or health objectives.

Technologies

Verum Exchange Launches a $10 Bonus for Online Mining of Verum Coin and Bitcoin

Verum Exchange Launches a $10 Bonus for Online Mining of Verum Coin and Bitcoin

Verum Exchange is expanding its online mining capabilities, allowing users to earn a $10 bonus while continuing to mine cryptocurrency directly from their smartphones. The feature is available not only in the currency converter app but also within Verum Messenger.

Online mining has long been part of the Verum ecosystem. Now, the company has added a new incentive to the existing feature — a bonus for participating in online mining.

The concept of online mining is changing the traditional perception of cryptocurrency mining. Users do not need to set up specialized mining equipment at home or deal with complex technical configurations. The feature can be accessed directly through the Verum digital ecosystem.

Verum Exchangehttps://exchange.verum.im 
Verum Messengerhttps://ios.verum.im

Continue Reading

Technologies

Supreme Court permits certain Trump mail-in voting restrictions before midterm elections

The Supreme Court has temporarily blocked a lower court ruling that prevented the Trump administration from implementing new restrictions on mail-in voting, allowing the administration to proceed with its plan to impose new requirements on states ahead of the midterm elections.

The Supreme Court on Monday sided with President Donald Trump for now in his effort to impose sweeping new restrictions on distributing mail ballots, putting on hold a lower-court ruling that had blocked key parts of the plan ahead of November’s midterm elections.

The justices, over three dissents, paused a ruling by U.S. District Judge Indira Talwani in Boston that prevented the Trump administration from carrying out portions of a March executive order involving the U.S. Postal Service and voter eligibility lists. The court’s three liberal justices dissented.

But the decision does not immediately allow the Postal Service to put its new mail-ballot system into effect.

A separate nationwide injunction issued Aug. 11 by U.S. District Judge Indira Talwani in Boston still blocks USPS from implementing the new procedures for the Nov. 3 elections. The administration would have to overcome that order as well.

The distinction was central to the Supreme Court’s decision.

The majority said Trump’s executive order itself does not require states to change how they conduct elections. Instead, it directs federal agencies to develop policies that could later impose requirements on states. Because those policies had not yet been implemented when 23 states and Washington, D.C., challenged the order, the court said the challenge was premature.

The justices stressed they were not deciding whether Trump’s order or the policies developed under it are ultimately legal.

“The Court’s disposition of this application does not mean that any measure taken by the Government to implement the Order will necessarily be lawful,” the majority wrote. “On that score, time will tell.”

The Postal Service last week finalized rules intended to carry out part of Trump’s order, including new requirements involving ballot envelopes, barcodes and information states must provide USPS. Those rules remain blocked by Talwani’s separate injunction.

The case now returns to the 1st U.S. Circuit Court of Appeals as the underlying legal fight continues. Some states have already started preparing to send ballots to military and overseas voters in early September.

Continue Reading

Technologies

Trump targets Iran’s trade lifelines — here are the countries most exposed

Washington’s threat of “economic D-Day” collides with a small group of governments that account for most of what remains of Iran’s foreign trade.

The U.S. announced an “economic D-Day” campaign Monday to isolate Iran from the global economy, threatening penalties against “enablers” that continue doing business with Tehran.

The move is part of Washington’s bid to sever the trade lifeline that has sustained Tehran’s economy through nearly six months of war.

While enforcement details are sketchy, the threat could still put the U.S. on a collision course with some of Tehran’s major trade partners.

China

China is the biggest buyer of Iranian oil and serves as a crucial link to the global economy for Tehran, accounting for about 90% of its oil exports, according to the U.S. government.

China reported $9.96 billion in bilateral trade with Iran in 2025, excluding the roughly $31.2 billion in unreported Iranian crude oil exports to China that year, according to the U.S.-China Economic and Security Review Commission.

Independent Chinese refiners take in the bulk of it, often rebranded as Malaysian or Indonesian crude and settled through intermediaries outside the dollar system, according to Kpler. The U.S. Treasury has sanctioned several of those refineries this year for Iranian oil purchases, while sparing Chinese financial institutions.

Beijing has openly opposed U.S. sanctions against Iran, arguing that economic pressure will not resolve the disputes. In May, China ordered domestic firms to disregard U.S. sanctions on five refiners linked to the Iranian oil trade.

While Beijing is unlikely to push back directly on Washington’s sanctions push, it will “quietly step up compliance” among state banks and oil companies to avoid getting caught in the net, said Dan Wang, China director at Eurasia Group, pointing to “a dichotomy between the official statement and the private practice.”

“Chinese authorities care more about dollar access in financing and market entry to the U.S.,” she said.

United Arab Emirates

The Emirates, located just 50 miles from Iran across the Persian Gulf, has long been a major trading hub for Iran.

The bilateral trade amounted to around $28 billion in 2024, when the Emirates was its largest source of imports, contributing over 30%, according to the World Trade Organization data. The UAE was also Iran’s third-largest export destination, making up 12% of its shipments, totaling more than $7 billion.

That relationship hit a snag last week as the UAE moved to suspend all trade and financial transactions with Iran, following two ballistic missiles fired toward Emirati territory, one of which targeted UAE-owned tankers.

Iran has relied on UAE banks and its financial system to access the world economy through illicit, often murky transactions, and cutting off Iran would require more forceful actions from Emirati authorities to crack down on opaque financial and trading activity, according to U.S.-based think tank The Washington Institute.

“The majority of Iran’s transshipment, smuggling, and shadow banking activity takes place in Dubai, so Washington must do what it can to help the UAE’s national leaders in Abu Dhabi convince and cajole Dubai’s leaders to play ball,” Matthew Levitt, a former U.S. Treasury official, wrote in a note on Monday.

Turkey

Turkey maintains significant commercial ties with Tehran, importing Iranian natural gas and exporting manufactured goods south.

The Turkey-Iran bilateral trade reached $5.7 billion in 2024, according to the Turkish Ministry of Foreign Affairs, with Ankara exporting mostly machinery and parts, chemical and agricultural products, while importing energy products from Tehran.

Meanwhile, under a 25-year gas supply contract between the two countries that expired at the end of July, Turkey’s imports of Iranian gas spiked this year while Iran’s share of Turkey’s total natural gas imports rose to 18.6%, according to local media.

While Ankara has sought to diversify toward other suppliers, expanding pipeline imports from Azerbaijan and Russia, it has, so far, not signaled that it intends to cut Iran off.

Iraq

Iraq, dependent on Iranian electricity and gas, has historically traded billions with Tehran.

Iran renewed a five-year contract in March 2024 to supply Iraq with up to nearly 660 billion cubic feet of natural gas a year, and electricity imports from Iran accounted for more than 30% of its electricity generation in 2023, according to the U.S. Energy Information Administration.

Iraq-Iran trade reached more than $10 billion in 2025, according to Reuters, with Tehran exporting food, consumer goods and other products to the Iraqi market. The trade has dwindled this year amid increased security risks in the region and intermittent disruptions along border crossings since the war started in late February.

Iraq reportedly pays Iran around $4 billion to $5 billion a year for natural gas for electricity generation. The fresh U.S. sanctions could curtail Baghdad’s payments for Iranian energy.

India

India, among Iran’s top five trading partners, has seen its bilateral trade with Iran fall in recent years to around $1.6 billion in the year ending March 2026, according to India’s Department of Commerce, down from $2.3 billion in the year through to March 2023.

New Delhi primarily exports rice, tea, sugar and pharmaceuticals to Iran, and imports dry and fresh fruits from Iran.

In April, India resumed importing crude oil from Iran following a seven-year halt, after the U.S. temporarily lifted sanctions on Iranian crude exports.

But those trades now will be tested if Washington makes good on its threat to sanction any entity, including Indian refiners, that have procured Iranian energy.

Continue Reading

Trending

Copyright © Verum World Media